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Abstract
HIV-1 replication is a tightly controlled mechanism which demands the interplay of host as well as viral factors. Both gp120
(envelope glycoprotein) and Nef (regulatory protein) have been correlated with the development of AIDS disease in
independent studies. In this context, the ability of HIV-1 to utilize immature dentritic cells for transfer of virus is pivotal for
early pathogenesis. The presence of C-type lectins on dendritic cells (DCs) like DC-SIGN, are crucial in inducing antiviral
immunity to HIV-1. Both gp120 and Nef induce the release of cytokines leading to multiple effects of viral pathogenesis. Our
study elucidated for the first time the cross-talk of the signaling mechanism of these two viral proteins in immature
monocyte derived dentritic cells (immDCs). Further, gp120 was found to downregulate the IL-6 release by Nef, depending
on the interaction with DC-SIGN. A cascade of signaling followed thereafter, including the activation of SOCS-3, to mediate
the diminishing effect of gp120. Our results also revealed that the anti-apoptotic signals emanated from Nef was put to halt
by gp120 through inhibition of Nef induced STAT3. Thus our results implicate that the signaling generated by gp120 and
Nef, undergoes a switch-over mechanism that significantly contributes to the pathogenesis of HIV-1 and widens our view
towards the approach on battling the viral infection.
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Introduction
HIV-1 infection is characterized by sustained activation of the
immune system. Dendritic cells are the first to encounter HIV-1 in
the mucosal genital tissues [1] and are positioned throughout the
peripheral immune system [2–4]. DCs are crucial for initiating
immune response due to their ability to present processed antigens
to recirculating naı¨ve T cells [5] after migrating to secondary
lymphoid organs. The initial step in HIV-1 infection occurs by
binding of the viral envelope glycoprotein gp120 to surface CD4
followed by interactions with CCR5 or both in T lymphocytes and
macrophages [6]. However, it has been seen that HIV-1 can
efficiently bind to receptors apart from CD4 in dendritic cells [7–
11]. A major C type lectin, DC-SIGN, found on DCs, has been
characterized as a gp120 binding protein of affinity higher than
that of CD4 [9]. HIV-1 internalization occurs through DC-SIGN
in both immature and mature DCs, thus leading to enhanced
infection via DC-SIGN within CD4 lymphocytes and through
trans-infection [12,13]. Hence DCs have significant roles in
aspects pertaining to innate and adaptive immunological respons-
es.
Based on molecular epidemiological data in humans the HIV-1
regulatory protein, Nef, has a key role to play in viral pathogenesis
[14–16]. Since animal models stand as evidence for the complete
development of AIDS by the presence of Nef [17,18], hence the
study of Nef on DCs appears to be of profound interest. Nef is a
27-kDa protein expressed early in the virus life cycle and
modulates several signaling pathways [19]. Exogenous Nef has
been detected in the sera of AIDS patients and in cultures of HIV-
1 infected cells [20]. Another crucial HIV-1 protein, gp120, which
is an envelope glycoprotein, is implicated in signaling mechanism,
extensively investigated in dendritic cells. The activation of cellular
signaling pathways leading to the production of cytokine and
chemokine genes by HIV-1 gp120 could facilitate viral replication
in the early phases of the viral life cycle [21]. Hence the impact of
the combined study of Nef mediated signaling in presence of
gp120 on DCs, is vital to understand the basis of the foundation of
HIV-1 pathogenesis.
During the initial phase of HIV-1 infection, primary cytokines
such as IL-6, IL-10, TNF-alpha, MIP-1alpha and MIP-1beta enter
the scenario [22–24]. These cytokines have pivotal roles in the
regulation of immune response despite their pleiotropy. HIV-1
hijacks the release mechanism of these cytokines since they serve as
the pillars of host immune system during viral entry. Our present
study, while estimating the level of these cytokines in vitro through
stimulation of immature DCs with gp120, Nef and a combination
of both the proteins, exhibited a drop in IL-6 titer when brought in
comparison to other cytokines. We therefore performed an in-
depth study to explore the pathway responsible for this observa-
tion.
Our experiments yielded the result where gp120 was found to
downregulate Nef dependent IL-6 release by the involvement of
SOCS-3, an important intracellular molecule responsible for
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terminating the damaging effects of cytokines. Several data have
showed the roles of individual HIV-1 proteins, gp120 and Nef in
the past [19–21,23–26]. However, what is not known is the
interaction of different signaling pathways initiated by these two
proteins. Since immature DCs serve as the target for HIV-1 attack,
hence it would be quite interesting to find out how these two
proteins act together during HIV-1 infection. Definitely there
might to be a switching mechanism between the two during the
viral life cycle. Here we have elucidated how immature DCs react
in the presence of both gp120 and Nef through a redundant
mechanism of cell activation. The consequent release of different
activating and inhibiting factors in the process furthermore
extends the impact of this crosstalk. Since immature DCs have
the unique capacity to act as vehicles for HIV-1 transmission [9],
hence we performed our experiments with immDCs to find out the
signaling mechanism arising due to the crosstalk of gp120 and Nef.
Our study will provide new leads to HIV-1 trafficking through
DCs for better understanding of AIDS pathogenesis. Thus we will
be able to know how gp120 and Nef enhance viral infection
without neutralizing the action of each other.
Results
Gp120 downregulates Nef dependent IL-6 release
Several cytokines have been reported to be produced by both
envelope glycoprotein gp120 [27–30] and Nef [31,32]. Hence we
studied the events that occur when gp120 and Nef act in the
presence of each other. As a first step we analysed the effect of
HIV-1 gp120 on Nef mediated cytokine release on immDCs. The
cells were subjected to treatment with gp120 and Nef separately
and also combining the both. The cytokines MIP-1alpha, MIP-
Figure 1. Measurement of cytokines in immDCs. The concentration of various cytokines (MIP- 1alpha, MIP- 1beta, IL-6, IL-10 and TNF- alpha) in
the supernatant of immDCs after incubating with either Nef (100 ng/ml), gp120 (4 mg/ml) or a combination of both Nef (100 ng/ml) and gp120
(4 mg/ml) in separate sets of experiments were measured. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’ t-
test, with the levels of significance defined as p*,0.05 and p**,0.01.
doi:10.1371/journal.pone.0059073.g001
Figure 2. gp120 downregulates Nef dependent IL-6 release.
ELISA of IL-6 concentration was measured in pg/ml in immDCs. The first
column denotes untreated cells; the second column denotes cells
treated with only gp120; the third column denotes cells treated with
only Nef; the fourth column denotes cells treated with both gp120 and
Nef; the fifth column denotes cells treated with heat denatured gp120
along with Nef. Data represent the mean6SEM (n= 3). Statistical
analysis was performed using Student’s t-test, with the levels of
significance defined as p*,0.05 and p**,0.01.
doi:10.1371/journal.pone.0059073.g002
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1beta, IL-6, IL-10 and TNF-alpha were ascertained in the
presence of gp120, Nef and combination of gp120 and Nef,
respectively (Fig. 1). Interestingly, it was observed that the level of
IL-6, which was induced by Nef, dropped significantly on
subjecting to treatment with both gp120 and Nef in immDCs.
The experiment was repeated with Nef and heat denatured gp120
proteins in immDCs (Fig. 2), which showed that active gp120
interacts with Nef and causes a downregulatory effect on Nef
induced IL-6 release. We next performed experiments with lower
concentration of HIV-1 proteins to see whether the effect of gp120
on Nef could be achieved at lower doses (in the context of HIV-1
infection). For this, we challenged the immDCs with Nef (Fig. 3A
and Fig. 3B) and gp120 (Fig. 3C and Fig. 3D) proteins separately
in independent sets of experiments under similar conditions to
observe the effect in both dose and time dependent manner. The
results indicated that the maximum release of cytokines from
immDCs occurred at concentrations of 4 mg/ml for gp120 and
100 g/ml for Nef. The downregulatory effect of gp120 on Nef was
then checked with infectious molecular clones. For this we infected
the immDCs with 1 ng/105 cells of (VSV-G) pseudotyped HIV-1
?nef, HIV-1 ?env and HIV-1 ?env/?nef strains along with wild type
ones. The expression of Nef was first verified in the immDCs
infected with the aforesaid viruses (Fig. 4A). The supernatants
from immDCs were collected at 12 and 24 hrs postinfection and
the level of IL-6 was measured through ELISA. The concentration
obtained was much less compared to those cells treated with
recombinant Nef and gp120 proteins. However the IL-6
suppression level could be easily distinguished in intact env and
env defective pseudoviruses (Fig. 4B). The infection of immDCs by
aforesaid HIV-1 viruses was evaluated through flow cytometry
(Fig. 4C). The rest of the results were verified with molecular
clones of HIV-1 (data not shown).
Figure 3. The effect of gp120 and Nef on various cytokines (MIP- 1alpha, MIP- 1beta, IL-6, IL-10 and TNF- alpha) in a dose and time
dependent manner. (A) The immDCs were incubated in presence of different concentrations of Nef with 0 ng/ml, 1 ng/ml, 25 ng/ml, 50 ng/ml,
75 ng/ml, 100 ng/ml and 125 ng/ml. The supernatant was collected after 24 hrs followed by measurement of cytokine concentrations through ELISA.
Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels of significance defined as p*,0.05 and
p**,0.01. (B) The immDCs were incubated in presence of Nef (100 ng/ml) for upto 24 hrs time. The supernatant was collected and the cytokine
concentrations were detected through ELISA. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with
the levels of significance defined as p*,0.05. (C) The immDCs were incubated in presence of different concentrations of gp120 (0 mg/ml, 1 mg/ml,
2 mg/ml, 3 mg/ml, 4 mg/ml and 5 mg/ml). The supernatant was collected after 24 hrs followed by measurement of cytokine concentrations through
ELISA. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels of significance defined as
p*,0.05 and p**,0.01. (D) The immDCs were incubated in presence of gp120 (4 mg/ml) for upto 24 hrs time. The supernatant was collected and the
cytokine concentrations were detected through ELISA. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-
test, with the levels of significance defined as p*,0.05.
doi:10.1371/journal.pone.0059073.g003
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Downregulation of Nef dependent IL-6 release relies on
the interaction of gp120 with DC-SIGN
Although the engagement of CD4 and other chemokine
receptors by gp120 is required for viral infection [6,33], yet data
have shown the involvement of C-type lectins such as DC-SIGN in
HIV-1 recognition by binding the HIV-1 gp120 [9]. Since gp120
was found to diminish Nef induced IL-6, hence we wanted to find
out whether any receptor interaction by gp120 was involved in the
inhibition of IL-6. The primary receptors present on the surface of
immDCs, i.e. CD4, CCR5 and DC-SIGN were targeted with
which gp120 generally bind. The expression of these receptors in
immDCs were analysed through FACS (data not shown) and the
receptors were silenced through specific siRNA individually. The
efficacy of receptor silencing both in the presence and absence of
Nef protein has been shown in Fig. 5A.
It was noted that silencing of CD4 and CCR5 did not cause any
alteration to the effect of gp120 on IL-6. The diminishing of IL-6
by gp120 was observable despite knocking down both CD4 and
CCR5. However, DC-SIGN silencing hindered the effect of
gp120. The cells transfected with DC-SIGN siRNA showed
enhanced expression of IL-6 compared to those where the
receptor was present (Fig. 5B). This proved that gp120 needs to
interact with DC-SIGN in order to carry out its inhibitory effect
on IL-6. Our observation was further confirmed by RT-PCR (data
not shown), where similar results were obtained. This established
that IL-6 release induced by Nef protein is downregulated by
gp120 via DC-SIGN receptor.
Figure 4. (A) Expression of Nef in the presence of wt, A¨nef, A¨env, A¨nef/A¨env (VSV-G) HIV-1 or mock infected immDCs. The immDCs
were infected with the wild type and mutant viruses. After 24 hrs, the cells were harvested and assayed for Nef expression by immunoblotting. aˆ-
actin served as an internal control. 4. (B) Nef expressed by HIV-1 induces release of IL-6. The immDCs were infected with either wt, A¨nef, A¨env, A¨nef/
A¨env (VSV-G) HIV-1. Cells were extensively washed and re-fed after infection. Supernatants were collected at 12 hrs and 24 hrs of infection. The
content of IL-6 was then measured by ELISA. Data represent the mean6SEM (n = 3). Statistical analysis was performed using Student’s t-test, with the
levels of significance defined as p*,0.05 and p**,0.01. 4. (C) Flow cytometry analysis for the detection of infection in immDCs. After 24 hrs of
infection with either wt, ?env, ?nef or ?env/?nef were analysed for the detection of the HIV-1 antigen (p24) by incubating with anti-p24 HIV-1
monoclonal antibody followed by staining with PE-conjugated anti mouse antibody. PE-conjugated isotype matched IgG served as control. Presence
of histogram peaks evidenced the occurrence of infection and validated our results.
doi:10.1371/journal.pone.0059073.g004
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Association of gp120 with DC-SIGN, releases IL-10 which
mediates the downregulation of Nef dependent IL-6
release
It has been evidenced that gp120 can interact with DC-SIGN to
induce IL-10 release [34]. However, it is not known whether this
IL-10 can exert downregulation of IL-6 induced by Nef. Hence we
verified the role of IL-10 by transfecting immDCs with IL-10
specific siRNA followed by confirming IL-6 expression. The
results showed that knock down of IL-10 in immDCs failed to
exhibit the inhibitory effect of gp120 on Nef induced IL-6 (Fig. 6),
i.e. the level of IL-6 expression in the presence of IL-10 siRNA
transfected cells was similar to the ones treated with Nef protein
alone in the absence of gp120. In this regard, it should be
mentioned that gp120 can induce IL-10 release in cell lines, both
in the presence and the absence of DC-SIGN. However, gp120
can downregulate the expression of IL-6 only when it interacts
with DC-SIGN, perhaps because the augmented release of IL-10
by gp120 on binding with DC-SIGN mediates the inhibitory effect
of gp120.
The IL-10 release by gp120 depends on the activation of
Raf-1 along with NF-kappa beta
The involvement of DC-SIGN with gp120 encouraged us to
trace the downstream signaling of DC-SIGN in order to verify
whether IL-10 release relies on the activation of any other
signaling molecule that gets induced after gp120-DC-SIGN
interaction. It has been evidenced that HIV-1 can mediate the
activation of Raf-1 kinase through the DC-SIGN signalosome,
thus modulating the cytokine responses to HIV-1 [35]. Raf-1
activation occurs through an interaction with the active form of
Ras-GTPase [36]. Also, Raf-1 activation by DC-SIGN can induce
phosphorylation of NF-eˆB to shape the adaptive immunity [35].
Hence, Ras-GTPase assay was performed to analyse DC-SIGN
dependent Raf-1 triggering by gp120. The immunoblotting
experiments showed that incubating immDCs with gp120 led to
the activation of Ras-GTP, which remained unaffected in presence
of Nef protein. Further, silencing of DC-SIGN receptor through
specific siRNA and kinase inhibitor (PP2) in separate experiments
blocked the Ras-GTP activation mediated by gp120 (Fig. 7A).
Next we checked the involvement of Raf-1, one of the downstream
effector molecule of Ras pathway. It was observed that gp120
could not mediate the phosphorylation of Raf-1 in immDCs by
pre treating the cells with PP2 (kinase inhibitor) and GW5074
(Raf-1 inhibitor) separately in independent experiments through
immunoblotting and FACS (Fig. 7B and Fig. 7C). This indicated
that gp120 leads to the activation of Ras followed by Raf in
immDCs by triggering DC-SIGN receptors. The knock down of
Raf-1 by Raf-1 specific siRNA and also treatment with Raf-1
inhibitor GW5074 in immDCs, in separate sets of experiments,
reversed the diminishing effects generated by gp120 on Nef
induced IL-6 expression i.e. gp120 could not downregulate Nef
induced IL-6 in presence of Raf-1 siRNA and GW5074 (Fig. 8).
Furthermore, it was also seen that incubation of immDCs with
gp120 causes activation of NF-eˆB, as evidenced by the ELISA and
immunoblotting experiments performed for the investigation of
Figure 5. Effect of receptor silencing on IL-6 concentration in the presence of Nef and gp120. (A) Efficacy of CD4, CCR5 and DC-SIGN
silencing mediated through specific siRNA (5 nM/ml) transfections in immDCs. The expression of specific receptors in immDCs was analysed both in
the presence and absence of Nef. The specific genes were checked using appropriate primers through RT-PCR. GAPDH served as internal control (B)
ELISA of IL-6 concentration in pg/ml in immDCs in the presence and absence of CD4, CCR5 and DC-SIGN. X-axis represents the presence or absence of
CD4 siRNA, DC-SIGN siRNA and CCR5 siRNA by ‘+’ and ‘---’ signs respectively in immDCs in the presence of both Nef and gp120. The concentration of
siRNA used was 100 nM. Y-axis represents the concentration of IL-6 in pg/ml. Data represent the mean6SEM (n= 3). Statistical analysis was
performed using Student’s t-test, with the levels of significance defined as p*,0.05.
doi:10.1371/journal.pone.0059073.g005
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p65, p50, p52, Rel-B and c-Rel subunits of NF-eˆB from the cytosol
and nuclear extracts of immDCs. Our experiments revealed that
p65 subunit is activated by gp120 (Fig. 9A) which then gets
translocated to nucleus from cytosol (Fig. 9B). Silencing of Raf-1
through specific siRNA prevents the translocation of p65 subunit
of NF-eˆB from cytosol to nucleus induced by gp120 (Fig. 9C),
which proved that NF-eˆB activation by gp120 relies on Raf-1
phosphorylation. Interestingly, it was also evidenced that silencing
of NF-eˆB diminished the IL-10 induction augmented by gp120
(Fig. 9D). This proved that the activation of both Raf-1 and NF-eˆB
downstream DC-SIGN are necessary in order to facilitate the
downregulation of IL-6 by gp120.
The activation of STAT3 by Nef induced IL-6 gets
suppressed on activation of IL-10 through gp120
STAT proteins are the effectors of cytokine signaling in several
hematopoietic cell lineages [37,38], some of which are targets for
HIV-1 infection. STAT3 activation is thought to have a role in cell
survival, as seen by the resistance to the anti- apoptotic effect of IL-
6 in STAT3 defective T lymphocytes [39]. The effect of Nef
induced IL-6 in immDCs was verified to find out whether IL-6
release in response to activation by Nef, is able to induce STAT3.
Our experiment revealed that Nef induces phosphorylation of
STAT3 along with the induction of IL-6 in a dose dependent
manner (Fig. 10). Silencing IL-6 in immDCs with IL-6 specific
siRNA failed to cause STAT3 activation, thus indicating the
involvement of IL-6 in Nef dependent STAT3 activation. Our
study elucidated that in the presence of gp120, Nef dependent
STAT3 activation gets suppressed (Fig. 11). This indicated that
gp120 inhibits STAT3 activation by interrupting Nef induced IL-6
secretion via IL-10 release.
Gp120 recruits SOCS-3 through IL-10 activation for
suppressing IL-6 and IL-6 dependent STAT3
It is known that cytokine stimulation induces a family of SOCS
proteins, whose predominant function is to block the generation of
the STAT signal from a cytokine receptor [40]. Genetic evidence
from mice and cells lacking SOCS-1 and SOCS-3 have showed
that these two proteins are required to reduce overall signaling
output from their target receptors [40]. Our experiments revealed
that IL-10 secreted by the interaction of gp120 with DC-SIGN
was responsible for diminishing IL-6 release. However, we wanted
to verify whether IL-10 was the terminal downstream factor of
gp120 mediated DC-SIGN signaling involved in diminishing IL-6
release or, whether the effect was being mediated through the
interplay of any cytokine induced inhibitor. Since SOCS-1 and
SOCS-3 are reported to be activated through IL-10 [41], hence
we performed the knock down of both SOCS-1 and SOCS-3 in
immDCs separately before proceeding further. The efficacy of
SOCS-1 and SOCS-3 knock down was confirmed by RT-PCR
(data not shown). It was seen that SOCS-1 silencing did not create
any alteration to the effect of IL-6 down regulation by gp120
activated IL-10, but transfection of the cells with SOCS-3 siRNA
reversed the obtained results (Fig. 12). The results clearly indicated
that the effect of gp120 on Nef was neutralized in SOCS-3 silenced
immDCs, i.e., gp120 mediated IL-10 release could not exhibit
suppression of Nef dependent IL-6 release in absence of SOCS-3.
This signified the role of SOCS-3 in this signaling cascade, since it
emphasized on the fact that IL-10 can bring about the
downregulation of IL-6 only through the involvement of SOCS-
3. Further SOCS-3 silencing revealed that gp120 was unable to
suppress STAT3 activation induced by Nef (Fig. 13).
Gp120 induces apoptosis by suppressing STAT3 induced
by Nef
Several evidences suggest the role of HIV-1 in inducing
apoptosis in many cell lines [42,43]. However, treating immDCs
with Nef did not exhibit any such event, thus showing that Nef
induces anti-apoptotic signal via activation of STAT3. Upon
incubating Nef pretreated immDCs with gp120, it was observed
that the anti-apoptotic effect of STAT3 gets diminished in a time
dependent manner (Fig. 14). This brings out the fact that gp120
suppresses the induction of STAT3 by Nef, which ultimately
reverses the anti-apoptotic signals, thus leading to complete
apoptosis.
Discussion
AIDS pathogenesis relies on the interplay of molecular
mechanisms that determine the immunological perspective. In
the present study we have shown an in vitro cross talk between
gp120 and Nef, which individually stand out as important HIV-1
proteins responsible for the viral pathogenesis. Nef induces IL-6
response in immDCs, which has numerous effects including the
activation of STAT3. The STAT family includes seven elements
[37,38] whose activation is involved in the response of a wide
number of cytokines, growth factors, and hormones. The
promoters of numerous anti-apoptotic genes are stimulated by
activated STAT3 and it has been witnessed that the expression of
Nef counteracts the HIV-1 induced apoptosis in lymphocytes [44–
46]. It can also be said that the cell survival mechanism is
generated by STAT3 activation, as reported by the resistance to
the antiapoptotic effect of IL-6 in STAT3-defective T lymphocytes
Figure 6. IL-10 knock down inhibits the downregulatory effect
of gp120 on Nef mediated IL-6 expression. ELISA of IL-6
concentration in pg/ml was performed in immDCs treated with Nef,
combination of Nef and gp120 and in the presence of IL-10 siRNA. Data
represent the mean6SEM (n = 3). Statistical analysis was performed
using Student’s t-test, with the levels of significance defined as p*,0.05
and p**,0.01.
doi:10.1371/journal.pone.0059073.g006
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[39]. Thus STAT3 activation in the Nef-expressing cells is
important for the interpretation of the role played by the Nef
protein in AIDS pathogenesis. Our results have demonstrated that
the effect of Nef is nullified in immDCs through IL-10. gp120
induces IL-10 release which in a time dependent manner causes
gradual inhibition of the anti-apoptotic effect of Nef by
suppressing the activation of STAT3. In other words, Nef
incubated immDCs cells, when treated with gp120, exhibits
apoptosis. The IL-10 release by gp120 is not a direct mechanism
and depends on the involvement of other factors such as Ras, Raf
and NF-eˆB activation. The IL-10 then binds to the IL-10 receptors
present on the surface of immDCs which causes the activation of
SOCS-3. The downregulatory effect of gp120 on Nef is then
carried out by SOCS-3 which actually blocks the IL-6 induction
by Nef.
Though gp120 can interact with different chemokine receptors
to carry out viral infection, yet it was evident from our
observations that the binding of gp120 to DC-SIGN receptor is
crucial for the downregulation of Nef by gp120. In this regard it is
important to mention that gp120 has various effects on DCs
including generation of immunosuppression [34]. The DC-SIGN
receptor present on the surface of immDCs interacts with HIV-1
gp120 and leads to the activation of Ras-GTPase activity which
further activates Raf-1. We have shown that the downregulatory
effect of gp120 on Nef involves the cooperation of several signal
molecules which are interlinked and finally lead to the obtained
result. gp120 interacts with DC-SIGN to induce Raf-1 by
Figure 7. Ras-GTP and Raf-1 activation is required for gp120 to implement its downregulatory effect on Nef induced IL-6. (A)
Immunoblot analysis for the detection of Ras-GTP in immDCs. Ras-GTP activation was measured in presence of gp120; Nef, gp120 and kinase inhibitor
(PP2); Nef, gp120 and DC-SIGN siRNA; Nef and gp120. The upper panel of the western blot analysis reveals that Ras-GTP gets activated in the
presence of gp120, both in the presence (5th lane) and absence (2nd lane) of Nef. This shows that Nef has no role in the activation process. However,
presence of kinase inhibitor (3rd lane) and knock down of DC-SIGN (4th lane) inhibit the activation of Ras-GTP. The lower panel of the blot denotes the
total Ras in the cells. The densitometric analysis corresponds to the respective bands obtained in immunoblotting. Data represent the mean6SEM
(n = 3). Statistical analysis was performed using Student’s t-test, with the levels of significance defined as p*,0.05. (B) Western blot analysis of Raf-1
phosphorylation at ser338 residue in presence of gp120; Nef and gp120; Nef; Nef, gp120 and kinase inhibitor (PP2); Nef, gp120 and GW5074. The
upper panel of the blot clearly shows that Raf-1 phosphorylation is facilitated by gp120. The lower panel denotes the total Raf-1 content of the cell.
Data represent the mean6SEM (n= 3). (C) FACS analysis of Raf-1 phosphorylation at ser338 residue in presence of gp120; Nef and gp120; Nef; Nef,
gp120 and kinase inhibitor (PP2); Nef, gp120 and GW5074 (Raf-1 inhibitor). The percentage on the upper right hand side of each histogram denotes
the cell percentage positively stained.
doi:10.1371/journal.pone.0059073.g007
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activating Ras-GTPase. This further leads to the activation of NF-
eˆB which is evident from translocation of the p65 fragment of NF-
eˆB in the nucleus and thereby triggers IL-10 release. IL-10 in turn
causes SOCS-3 activation which ultimately delivers the down-
regulatory effect of gp120 on Nef induced IL-6 and STAT3 in
immDCs. The putative illustration of the entire study has been
represented in Fig. 15. The study of the influences of gp120
appears to be of profound interest since it interacts with the host
receptors primarily during the viral life cycle. In this study, we
have analysed that in immDCs, the interaction of gp120 with
other host receptors (CD4, CCR5) does not put any impact on Nef
induced cytokines (IL-6, TNF-alpha etc). However, gp120- DC-
SIGN interaction leads to the downregulation of IL-6 expression.
Since Nef mediated anti-apoptotic effects are crucial for viral
replication in the host, hence there is every probability that after
accomplishing viral replication, HIV-1 switches off the anti-
apoptotic effect of Nef by suppressing the STAT3 activation in
immDCs.
It is still unclear whether the DC-SIGN expressing immDCs are
kept alive by the virus through activation of anti-apoptotic genes
until it reaches the lymph node and then sacrificed to carry on
infection. However, the significance of the cross-talk between the
signaling pathways of Nef and gp120 cannot be over looked, since
it could make a better understanding of the process by which HIV-
1 modulates signaling in immDCs. This could be vital in the
development of new therapeutic approaches that might ultimately
restrict or decrease the size of cellular virion reservoirs in HIV-1-
infected patients.
Materials and Methods
Cell culture and cell treatment
Human monocytes were isolated from buffy coats of human
blood (the approval was provided by Institutional Ethical
Committee of National Institute of Cholera and Enteric Diseases)
with a Ficoll gradient, followed by hypertonic density centrifuga-
tion in Percoll. After 30-mins culture in RPMI supplemented with
5% human serum and 1% L-glutamine, the monocytes became
adherent and were washed thrice with SMEM Spinner medium to
remove contaminating lymphocytes.
In differentiation experiments, monocytes were seeded at 56105
cells/ml in tissue culture dishes with no change of the culture
medium after addition of the differentiation inducer(s). Unless
otherwise indicated, IL-4 was added into the cells 24 hours after
treatment with GM-CSF (15 ng/ml) (Calbiochem, USA) and
differentiation allowed to proceed for 72 hours. For subsequent
analysis, differentiated monocytes were detached from tissue
culture plates by incubation in PBS on ice.
The immDCs obtained from monocytes were used for
experimental purpose on the 3rd day of their differentiation.
The cells were treated with recombinant Nef (upto 100 ng/ml)
and gp120 (upto 4 mg/ml) protein. The gp120 protein was purified
from HIV-1 CCR5 isolate BaL in monomeric form [47] (AIDS
Research and Reference Reagent Program of the Division of
AIDS, National Institute of Allergy and Infectious Diseases, US
National Institutes of Health). Each sample was processed after
addition of 1 volume of 1/2 PBS, using the Endofree Red 5/1
Endotoxin removal kit (Profos AG). After endotoxin removal the
endotoxin levels were ,3 EU/mg.
Immature DCs were separately treated with PP2 (20 mM)
(Calbiochem, USA), GW5074 (25 mM) (Calbiochem, USA), BAY-
11-7082 (20 mM) (Calbiochem, USA) in different sets of
experiments.
Virus preparation and infection
The NL4-3 HIV-1 was prepared following the protocols as
described elsewhere [48] and pseudotyped with the envelope
glycoprotein of the Vesicular Stomatites Virus (VSVG). These
viruses were obtained as supernatants of 293 T cells after 48 hrs.
This was mediated by calcium phosphate co- transfection of the
pUc19/NL4-3 molecular clone in a molar ratio of 5:1 with a
plasmid expressing the VSV-G with early CMV promoter.
Ultracentrifugation was performed to clarify and concentrate
supernatant [49]. Briefly, the A¨env HIV-1 molecular clone was
constructed by inserting the NL4-3 SalI/BamHI fragment deleted
of the BglII/BglII region in the SalI and BamHI sites of a pUc19/
NL4-3 derivative lacking the whole nef gene and carrying a
polylinker at the end of the env gene. The HIV-1 capsid (CA) p24
contents were measured by quantitative ELISA (Perkin Elmer,
USA). A total of 10 ng of pseudotyped HIV-1 was used to infect
immDCs. The experiment of viral adsorption was carried out in
24-wells plates followed by incubation of cells for 1 h at 37uC with
the viral inoculum (dilution performed in 100 ml of complete
medium). Later, after the removal of viral inoculum, cells were
washed and supplemented with 300 ml of complete medium.
FACS analysis was performed to calculate the percentage of cells
expressing intracytoplasmic HIV-1 p24 related products. The cells
were at first incubated with FACS permeabilization buffer
(Santacrutz, USA). The primary labeling was carried out at room
temperature with a 1/50 dilution of mouse anti HIV-1 p24 mAb
(Santacrutz, USA). The secondary staining was performed with
PE-conjugated anti mouse polyclonal antibody (Santacrutz, USA).
Figure 8. Inhibition of Raf-1 prevents the downregulatory
effect of gp120 on Nef induced IL-6. ELISA of IL-6 concentration in
pg/ml was performed in immDCs in presence of gp120; Nef; Nef and
gp120; Nef, gp120 and Raf-1 siRNA; Nef, gp120 and GW5074. Data
represent the mean6SEM (n = 3). Statistical analysis was performed
using Student’s t-test, with the levels of significance defined as
p*,0.05, p**,0.01.
doi:10.1371/journal.pone.0059073.g008
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cDNA synthesis and PCR
Subsequent to various treatments of immDCs for 24 hrs at
37uC, the total cellular RNA from 26105 cells was isolated by
Total RNA easy kit (Qiagen, USA) following the manufacturer’s
protocol. 10 ml of the eluted RNA was subjected to reverse
transcription by the M-MLV Reverse Transcriptase RNase H
Minus (Invitrogen, USA), at 40uC for 60 min with random
hexamer (Applied Biosystems, USA) in a total volume of 25 ml.
3 ml of RT product was used as the template for the first round of
PCR. The PCR reaction was carried out in a final volume of 50 ml
containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM
MgCl2, 0.2 mM each deoxynucleoside triphosphate, 0.2 mM of
each specific primer, 2.5 U of ampliTaq DNA polymerase
(Applied Biosystems, USA). The reverse transcription and PCR
amplifications were carried out with appropriate negative controls
to detect any possible contamination during the experiments.
PCR amplification was performed with cDNA using primer
pairs specific for IL-6, (upstream primer 59-GAGAAAGGAGA-
CATGTAACAAGAGT-39; downstream primer 59-GCGCA-
GAATGAGATGAGTTGT-39), IL-10 (upstream primer 59-
ATGCCCCAAGCTGAGAACCAAGACCCA-39; downstream
primer 59-TCTCAAGGGGCTGG GTCAGCTATCCCA-39),
CD4 (upstream primer 59-GCAGAGCGG ATGTCTCAGAT-
39; downstream primer 59-CTACATTCATCTGGTCCGCAG-
39), CCR5 (upstream primer 59-CAAAAAGAAGGTCTTCAT-
TACACC-39; downstream primer 59-
CCTGTGCCTCTTCTTCTCATTTCG-39, DC-SIGN (up-
stream primer 59-GCCACCCCTGTCCCTGGGAATG-39;
downstream primer 59-TAAAGGTCGAAGGATGGAGA-
GAAG-39, SOCS-1 (upstream primer, 59-GAGAG CTTCG
ACTGC CTCTT-39; downstream primer, 59-AGGTA GGAGG
TGCGA GTTCA-39), SOCS-3 (upstream primer, 59-CTCAA
Figure 9. Translocation of different NF-eˆB subunits (p65, p50, p52, Rel-B, c-Rel) in immDCs from cytosol denoted as ‘C’ to nucleus
denoted as ‘N’ in presence of gp120 (4.0 mg/ml). (A) DNA- binding ELISA analysis of the different subunits of NF-eˆB in the presence of gp120.
Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels of significance defined as p*,0.05,
p**,0.01. (B) Immunoblotting analysis of the translocation of the different subunits of NF-eˆB from cytosol denoted as ‘C’ to nucleus denoted as ‘N’. aˆ-
actin served as the internal control. (C) Immunoblot analysis of the translocation of p65 subunit of NF-eˆB from cytosol denoted as ‘C’ to nucleus
denoted as ‘N’ in presence of gp120 and a combination of gp120 and Raf-1 siRNA. aˆ- actin served as the internal control. (D) Effect of NF-eˆB p65
silencing in the induction of gp120 dependent IL-10 release. The immunoblot denotes the efficacy of silencing p65 subunit with aˆ-actin serving as
internal control. The bar diagram denotes the diminished expression of IL-10 in the presence of NF-eˆB p65 siRNA. Data represent the mean6SEM
(n = 3). Statistical analysis was performed using Student’s t-test, with the levels of significance defined as p**,0.01.
doi:10.1371/journal.pone.0059073.g009
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GACCT TCAGC TCCAA-39; downstream primer, 59-TTCTC
ATAGG AGTCC AGGTG-39) and GAPDH (upstream primer,
59-TGATG ACATC AAGAA GGTGG-39; downstream primer,
59-TTACT CCTTG GAGGC CATGT-39). The predicted
products for IL-6, IL-10, CD4, CCR5, DC-SIGN, SOCS-1,
SOCS-3, and GAPDH were 170, 352, 175, 189, 260, 562, 554,
and 244 bp respectively. The PCR products were separated on a
2% agarose gel and visualized by ethidium bromide staining.
Figure 10. Nef induces phosphorylation of STAT3 along with IL-6 in a dose-dependent manner. ELISA analysis showed that both IL-6 and
p-STAT3 get induced by Nef in immDCs. The X- axis denotes the dosage of Nef in ng/ml and the Y-axis denotes the OD obtained at 450 nm. Data
represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels of significance defined as p*,0.05.
doi:10.1371/journal.pone.0059073.g010
Figure 11. gp120 activates IL-10 in a dose dependent manner unlike IL-6 and IL-6 induced STAT3 phosphorylation which get
downregulated. ELISA analysis showed the increase of IL-10 expression through gp120 in contrast to IL-6 and IL-6 induced STAT3 phosphorylation
which exhibited a gradual decrease in concentration depending on the dosage of gp120. The X-axis shows the combined dosage of Nef and gp120,
where Nef dosage has been kept fixed at 100 ng/ml and the gp120 dosage has been varied from 0.5 mg/ml to 4.0 mg/ml. The Y-axis denotes the OD
obtained at 450 nm. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels of significance
defined as p*,0.05.
doi:10.1371/journal.pone.0059073.g011
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RNA interference
immDCs were transfected with upto 100 nM siRNA with
transfection reagents DF4 (Dharmacon, USA), according to the
manufacturer’ protocol. The siRNAs used were: DC-SIGN
siRNA, CD4 siRNA, CCR5 siRNA, NF-eˆB p65 siRNA
(Santacrutz Biotechnology, USA), Raf-1, SOCS-1, SOCS-3 and
IL-10 SMARTpool; nontargeting siRNA pool, as a control
(Dharmacon, USA). This protocol resulted in nearly 100%
transfection efficiency as determined by flow cytometry of cells
transfected with siGLO-RISC free-siRNA (Dharmacon, USA). At
72 hrs after transfection, cells were used for experiments. Silenced
expression of Raf-1, SOCS-3, SOCS-1, IL-10 and GAPDH were
confirmed at the mRNA level by quantitative real-time PCR.
Ras pull-down assay
Precipitation of active GTP-bound Ras from cell lysates was
performed with Raf-RBD-GST (Upstate Biotechnology, USA) as
previously described [50]. This was followed by SDS-PAGE and
immunoblotting with anti-Ras antibody (BD Bioscience, USA).
Total Ras was detected in the cell lysates to confirm equal
amounts.
Raf-1 phosphorylation assay
Raf-1 phosphorylation was measured by immunoprecipitation
of immDCs with anti-Raf-1 (Upstate Biotechnology, USA)
followed by immunoblotting with anti-phospho-Raf (Ser338) (Cell
Signaling Technologies, USA). Phosphorylation at ser338 residue
of Raf-1 was also confirmed by flow cytometry. The cells
underwent a stimulation of 15 minutes with gp120, Nef or both
before carrying out the experimental procedure.
NF-eˆB phosphorylation assay
Immature monocyte derived DCs nuclear extracts were
prepared with the NucBuster protein extraction kit (Novagen,
USA), and 5 mg of nuclear extract was used to determine the
specific subunits within the DNA binding NF-eˆB dimers with the
TransAM NF-eˆB family kit (Active Motif, Carlsbad, CA),
according to the manufacturer’s protocol. The p65 subunits from
cell lysates was captured with the Pathscan phospho-NF-eˆB p65
(Ser536) sandwich ELISA kit (Cell Signaling Technologies, USA),
according to the manufacturer’s protocol. Total p65 was detected
with rabbit anti-p65 pAbs (Active Motif, Carlsbad, CA), p65
phosphorylated at Ser536 was detected with rabbit anti-phospho-
p65 (Ser536) pAbs (Cell Signaling Technologies, USA), and
acetylated p65 was detected with rabbit anti-acetyl-lysine pAbs
(Upstate Biotechnology, USA).
Immunoprecipitation
Immature monocyte derived DCs cells were washed twice with
PBS and solubilized in 1 ml of lysis buffer (0.5% Nonidet P-40,
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM NaF, 1 mM
EDTA, 1 mM Na3VO4, 0.25 mM PMSF, 5 mg/ml aprotinin,
1 mg/ml leupeptin, 1 mg/ml pepstatin, and 15% glycerol) for
30 min at 4uC. Insoluble material was removed by centrifugation,
and the cell lysates were incubated with specific antibodies anti-
Ras (BD Bioscience, USA); anti-Raf-1 (Upstate Biotechnology,
USA); anti-STAT3 (Santa Cruz Biotechnology, USA) overnight at
4uC. The immune complexes were bound to protein A-Sepharose
(2.5 mg/ml in lysis buffer) for 1 h at 4uC. After centrifugation, the
Sepharose beads were washed three times with washing buffer
(0.05% Nonidet P-40, 50 mM Tris-HCl (pH 7.4), 100 mM NaCl,
1 mM NaF, 1 mM EDTA, 1 mM Na3VO4, and 15% glycerol).
The samples were boiled in gel electrophoresis sample buffer; the
Figure 12. IL-6 expression in immDCs on silencing SOCS-1 and SOCS-3. ELISA analysis reavealed the diminishing of IL-6 expression on
subjecting immDCs, incubated with Nef and gp120, to SOCS-1 knock down. However, silencing SOCS-3 caused an increase in the expression of IL-6 in
a dose dependent manner. The X-axis denotes the dosage of SOCS-1 siRNA and SOCS-3 siRNA in nM/ml. The Y-axis denotes the concentration of IL-6
in pg/ml. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels of significance defined as
p*,0.05.
doi:10.1371/journal.pone.0059073.g012
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precipitated proteins were separated on SDS-polyacrylamide gels
(7.5% acrylamide), transferred to nitrocellulose membranes and
probed with appropriate antibodies.
Immunoblotting and immunodetection
The electrophoretically separated proteins were transferred to a
nitrocellulose membrane by the Western blotting method.
Nonspecific binding sites were blocked with 10% BSA in TBS-N
(20 mM Tris-HCl (pH 7.4), 137 mM NaCl, and 0.1% Nonidet P-
40) for 15 min. The blots were incubated with the respective
primary Abs in TBS-N for 1 h at room temperature. Primary
antibody incubation was followed by incubation with horseradish
peroxidase-conjugated secondary antibodies (Santa Cruz Biotech-
nology, USA) and detection by enhanced chemiluminescence kit
(Millipore, USA) was performed during immunoblot analysis. The
antibodies used were anti-Ras (BD Bioscience, USA), anti- NF-eˆB
p65, p50, p52, Rel-B, c-Rel antibodies (Santa Cruz Biotechnology,
USA) anti-Raf-1 (Upstate Biotechnology, USA), anti-phospho-Raf
(Ser338) (Cell Signaling Technology, USA), anti-STAT3 (Santa
Cruz Biotechnology, USA) and phosphotyrosine-specific STAT3
(p-Tyr-705) (Santacrutz Biotechnology, USA). Anti-aˆ-actin (BD
Biosciences, USA) served as an internal control. Molecular weight
markers (Bio-Rad Laboratories, USA) were loaded to ensure that
proteins of interest were at the appropriate position.
Flow cytometry
The expression of DC-SIGN, CD4 and CCR5 on the cell
surface of immDCs, phosphorylation of Raf-1 and determination
of apoptosis were analysed by FACS. Prior to flow cytometry, the
cells were fixed for 10 min in 3% (wt/vol) paraformaldehyde and
then permeablized for 10 min at 4uC in 90% (vol/vol) methanol.
Viable cell counts were obtained by enumerating cells that
excluded trypan blue dye. The antibodies used were anti- DC-
SIGN mouse monoclonal, anti- CD4-PE conjugated mouse
monoclonal, anti- CCR5 mouse monoclonal (BD Biosciences,
USA), anti- phospho-Raf (Ser338) (Cell Signaling Technology,
USA). Secondary staining was performed, where applicable, with
Figure 13. Effect of SOCS-3 silencing on STAT3 phosphorylation in the presence of Nef and gp120. (A) Western blot analysis denotes
the phosphorylation status of STAT3 on subjecting immDCs incubated with Nef+gp120 to SOCS-3 siRNA in a dose dependent manner. The upper
panel refers to p-STAT3 whereas the lower panel denotes the total STAT3 in immDCs. ‘U’ refers to untreated cells and 1–5 denote the dosage of
SOCS-3 siRNA in nM/ml. (B) ELISA analysis of p-STAT3 under the same conditions. The X-axis denotes the dosage of SOCS-3 siRNA and the Y-axis
denotes the OD obtained at 450 nm. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels
of significance defined as p*,0.05, p**,0.01.
doi:10.1371/journal.pone.0059073.g013
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PE-conjugated secondary antibodies (Santa Cruz Biotechnology,
USA).
To detect apoptotic cells, the flow cytometric analysis of
propidium iodide (PI)-stained nuclei was performed. In brief, cells
were washed with phosphate-buffered saline (PBS) and then
incubated in hypotonic lysing buffer (0.1% sodium citrate, 0.3%
Nonidet P-40, and 50 mg/mL PI) at 4uC for 30 minutes.
Alternatively, cells were stained with annexin V conjugated to
phycoerythrin (PE) (BD Bioscience, USA) and vital dye 7-
aminoactinomycin D (7-AAD; PharMingen). Cultured cells were
washed with PBS, resuspended in binding buffer (10 mM HEPES
[N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid], 140 mM
NaCl, and 2.5 mM CaCl2), and incubated with annexin V-PE and
7-AAD (1.25 mg/mL) at room temperature for 15 minutes. Flow
cytometry analyses were performed in a flow cytometer (BD FACS
ARIA II, USA) by BD FACS Diva Software 6.0.
ELISA
Cells were incubated with 4 mg/ml gp120 and 100 ng/ml Nef
for 24 h. Culture supernatants were harvested, and MIP- alpha,
MIP-beta, IL-6, IL-10 and TNF-alpha concentrations were
determined by using specific Opt ELISA kit (BD Biosciences,
USA).
Statistical analysis
The results were expressed as the mean6standard error of the
mean (SEM), where applicable of three independent experiments.
The data were analyzed by Student’s t-test. The p values of ,0.05
were considered as significant.
Figure 14. Relative measurement of the rate of apoptosis in immDCs upon subjecting them to treatment with Nef and gp120. (A)
ELISA analysis of the apoptosis rate in immDCs upon subjecting them to treatment with Nef and gp120 in individual sets of experiments. The dosage
of Nef and gp120 were 100 ng/ml and 4 mg/ml respectively. X-axis denotes the combined dosage of Nef and gp120. Y-axis represents the percentage
of annexin positive cells. Data represent the mean6SEM (n= 3). Statistical analysis was performed using Student’s t-test, with the levels of
significance defined as p*,0.05 and p**,0.01. (B) FACS analysis of apoptotic immDCs cells on treating with gp120, Nef and combination of gp120
and Nef in a time dependent manner. The percentage denoted on the right side of each histogram denotes the positively stained cells.
doi:10.1371/journal.pone.0059073.g014
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